Screener
Immix Biopharma, Inc. IMMX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $482.51M.
The source filing: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 5:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001493152-26-021764
FAQ
- What is Immix Biopharma, Inc.'s market capitalization?
- Immix Biopharma, Inc. (IMMX) reported market capitalization of $482.51M in Q1 2026.
- How has Immix Biopharma, Inc.'s market capitalization changed year-over-year?
- Immix Biopharma, Inc.'s market capitalization increased by 936.0% year-over-year, from $46.57M to $482.51M.
- What is the long-term trend for Immix Biopharma, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Immix Biopharma, Inc.'s market capitalization has grown at a 53.8% compound annual growth rate (CAGR), from $49.24M to $275.6M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Immix Biopharma, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude